Abstract Control of human cytomegalovirus (HCMV) infection and prevention of associated diseases in immunocompetent hosts are ensured mainly by CD8+ T cells, in spite of numerous viral tricks to impair antigen presentation and activation of T cells. At sites of primary infection, dendritic cells (DCs) are in the forefront to ensure capture of viral antigens and their capacity to bypass the eVects of viral immunoevasins is crucial in moulding CD8+ T cell repertoire. In HCMV-seropositive donors, the spectrum of CD8+ T cells speciWcities was shown to include immediate-early (IE), early (E) and late (L) gene products, a surprising Wnding if we consider that expression of immunoevasins could paralyse infected DCs from the IE phase of infection. In the present report, we suggest that uninfected dendritic cells could acquire HCMV-antigens derived from input virus or neosynthesis, either in soluble forms or in association with infected dead cells resulting from death-ligand-mediated apoptosis and necrosis. Activation of naïve CD8+ T cells could then occur in lymph nodes through cross-presentation by antigen-loaded DCs, providing an explanation for shape and size of the memory compartment.
Introduction
Clearing of a viral infection depends mostly on the ability of the host to mount an eYcient primary anti-viral response and to get it in memory to overcome future viral challenge. In this process, dendritic cells (DCs) are crucial as they are sentinels located in most organs to monitor entry of viruses and initiate activation and proliferation of anti-viral T cells in lymph nodes. Two subsets of dendritic cells, plasmacytoids and myeloids, are now considered to play a role in innate as well as in adaptive response against viruses through both secretion of anti-viral type I interferons and activation of speciWc naïve T cells. Because of their vital role in inducing potent anti-viral immune responses, dendritic cells are major target for viruses and viral products which aim at blocking their function at any stage of antigen presentation, migration to secondary lymphoid organs and activation of T cells. Moreover, some viruses such as HIV and human cytomegalovirus (HCMV) use the C-type lectin receptor DC-SIGN on dendritic cells as a vector to ensure their transmission to other cells either in the periphery or in lymph nodes [1, 2] . Direct arguments that DCs are real targets for HCMV in vivo are suggested, for instance, by the ability of the virus to infect hematopoietic progenitor cells [3] and by the presence of viral DNA in puriWed DCs from viremic renal transplant patients as well as from healthy virus carriers [4, 5] . HCMV is a latent herpesvirus, which can be considered as a spearhead in exploiting co-existence with the host to develop numerous immunoevasion mechanisms, and virus-encoded immunoevasins have been described that impair many of dendritic cells functions including antigen presentation to CD4+ and CD8+ T cells [6] . Even though CD4+ T cells play a role in mounting anti-viral response, cytotoxic CD8+ T lymphocytes (CTL) are considered as the main eVectors involved in protection against CMV-associated diseases, as demonstrated by in vivo adoptive transfer in mouse infected with mouse CMV (MCMV) [7] and in bone marrow transplanted humans [8, 9] . CTL are supposed to exert their anti-viral activity on target cells to ensure protection of the host against HCMV, either in primary infection or reinfection or reactivation of the latent virus. This raises the question of how a memory T cell repertoire against HCMV could be moulded in conditions where DCs are supposed to be paralysed by immunoevasins, and how eVector CTL could ensure eradication of infected cells in tissues after re-infection or reactivation. Surprisingly, the CTL repertoire against HCMV appeared to exhibit broader speciWcities than expected, including proteins available at any stage of the virus cycle (immediate-early IE, early E, late L) and the question takes even more sense with respect to the fact that immunoevasins could be produced in the IE phase of infection. In response to this question, we can imagine multiple scenarios where the kinetics of events takes a major part including (1) time points at which immunoevasins are produced in infected cells and how eYcient they are with respect to MHC polymorphism, (2) HCMV strains variability and virulence and (3) how long it takes for cells to produce new virions, for antigen-loaded DCs to reach lymph nodes and for activated CTL to migrate back to the site of infection where they could encounter newly infected targets.
Besides these possible scenarios, cross-presentation of HCMV antigens by uninfected DCs to CD8+ T cells could be considered as a key process in initiating CTL response provided that viral proteins are made available for ingestion and processing by DCs and that they can be transported to lymph nodes for activation of naïve T cells. All of these points will be discussed throughout the present paper.
Alteration in dendritic cells functions by HCMV
Innate anti-viral response Dendritic cells are crucial in host innate defence since they are in the Wrst line of virus sensing at primary sites of infection through binding to pathogen recognition receptors (PRR) such as toll-like receptors (TLR), expressed either at the cell surface or in cell compartments (for review see [10] ). Interactions between the envelope glycoprotein gB of HCMV and TLR2 have been described [11] . Binding to the receptor, induced secretion of proinXammatory cytokines but did not take part in the activation of IFN-/ secretion by infected cells [12] , suggesting that TLR2 activation by HCMV could not beneWt the host. Interestingly, it is known that TLR are also involved in the release of anti-inXammatory cytokines and that TLR2 ligation could be a strong mediator of anti-inXammatory eVects, including the secretion of IL-10, IL-4 and activation of regulatory T cells (Treg) (for review see [13] ). We may then assume that triggering of TLR2 by HCMV on DCs could provide the virus with an additional trick to resist the host defence through activation of anti-inXammatory mechanisms. Besides this putative TLR2-mediated immunosuppression, an additional escape mechanism could be considered due to the ability of HCMV to bind to DC-SIGN on dendritic cells, another PRR known to mediate suppression of DCs function in models of bacterial infections [14] . Altogether, these hypotheses remain to be sustained by experiments on DCs either by the myeloid or plasmacytoid subset.
CD8+ T cell response and HCMV immunoevasins ( Fig. 1) Cytotoxic CD8+ T cells are the main eVectors involved in the clearing of HCMV-infected targets and it was not surprising that during its evolution with the host, the virus ensured its protection against CTL by encoding the proteins, which were able to disrupt the major histocompatibility complex (MHC) class I antigen processing pathway. Numerous viral gene products have been identiWed with the ability to impair the molecular cascade leading to the transport of MHC-I-peptide complexes from the endoplasmic reticulum (ER) to the surface of antigen presenting cells. The US2 to US11 region of the genome, encodes proteins (US2 and US11), which translocate the newly synthesized MHC class I heavy chains from ER to the cytosol for their degradation by proteasomal enzymes. Through its binding to the transporter associated with antigen processing (TAP), the US6 gene product blocks the translocation of peptides from the cytosol to ER thus impairing their association with MHC class I heavy chains. Finally, even though some MHC-I-peptide complexes could escape, the US3 protein would cause their retention in the ER, thereby avoiding their transport to the cell surface (reviewed in [6] ). Providing that all these escape mechanisms are able to block antigen presentation in infected DCs, we may ask how the host could mount a CD8+ T cell response against HCMV following primary infection, and how these eVectors could be eYcient in controlling re-infection or virus reactivation in latently infected healthy individuals? We can Wrst assume that eYciency of immunoevasins could be lower in vivo than in vitro and even in some cell types compared to others. Indeed, besides their locus-preference abilities to target class I heavy chains of HLA-A and -B but not -C and -G [15] , US2 and US11 proteins were shown to exhibit diVerent eYciencies in dendritic cells compared with Wbroblasts and astrocytoma cells [16] . The notion that, even though they are produced very early after infection, immunoevasins could be less eYcient in vivo than expected from in vitro studies is supported by recent Wndings demonstrating a broad repertoire of CD8+ T cells with speciWcities against IE, E and L proteins.
T cell repertoire against HCMV exhibits a broad pattern of speciWcities despite expression of immunoevasins: possible explanations
To examine the frequency and speciWcity of CD8+ CTL, a recent study using Wbroblasts as antigens presenting cells infected with a mutant strain deleted of the US immunoevasins, showed that most eVector T cells were directed against IE and E antigens [17] . These data suggest that after primary infection in vivo, naïve T cells could be activated by DCs which acquired IE and E proteins available before the time point at which US immunoevasins are expressed in amounts suYcient to exert their blocking activities. We can also assume that proteins contained in the viral tegument like pp65 and pp150, as well as proteins encoded by viral RNA entrapped during assembly of new virions, could be processed into the MHC-I proteasomal machinery, immediately after adsorption of the virus to the cell surface. Presentation of input pp65 to eVector memory CD8+ T cells in vitro has been demonstrated after infection of monocytesderived myeloid DCs with either the laboratory strain AD169 [18] or VHLE (personal data), a clinical isolate of HCMV, demonstrating that endogenous viral gene expression was not required. We further showed that incoming pp65 could be processed and presented to CD8+ T cells by non-professional antigen presenting cells such as astrocytoma cell line U373MG, infected with AD169 for 6 h [19] . Even though direct presentation of input proteins by DCs in vitro required high multiplicity of infection, we have no information on requirements to make this process eYcient in vivo, and moreover, to ensure priming of naïve T cells.
An extensive analysis of CD8+ T cell responses against HCMV in seropositive blood donors, by using an IFN-ELISPOT assay with synthetic peptides, revealed a broad repertoire of viral antigens encoded in the immediate-early, early, and late phases of replication, even including structural proteins like gB [20] . Within the numerous antigens recognized by memory CD8+ T cells of healthy HCMVseropositive donors tested with various HLA haplotypes, IE1 and pp65 were the most immunodominant, conWrming observations claimed by several groups for many years. Moreover, CTL detected in young infants with HCMV infection were directed at both IE1 and pp65 and their appearance correlated with decrease in viral load [21, 22] . This supports the notion that immunodominance could be governed by antigenic dominance, reXecting antigen amounts available at the right time when immunoevasins are not yet eVective. Overall it seems that the immunodominance hierarchy in primary response against HCMV could be related to timing of viral antigen expressed in DCs and present in their vicinity. This was corroborated by a more recent study intended to screen the immunogenicity of 213 HCMV open reading frames (ORF), using cytokine Xow cytometry and overlapping 15-mer peptides [23] . This study demonstrated the ability of peptides from 151 ORF to induce activation of CD4+ and CD8+ T cells from HCMVseropositive donors with various MHC haplotypes, providing additional proof that the spectrum of memory T cells against the virus is broader than expected. We may then ask whether the kinetics of viral replication at sites of virus entry could be connected to induction of responses against such a broad spectrum of IE, E and L antigens.
We can make the assumption that in tissue cells which are targets of primary infection, for instance in mucosa, a productive lytic cycle could be shortly achieved so that soluble as well as cell-associated antigens could be available for internalization by DCs. On the other hand, we can consider that during this primary phase, new virions could be formed and bind to still uninfected cells. Then, CD8+ T cells directed against incoming tegument proteins and IE antigens and which acquired their eVector function in the early days following virus entry, could kill these new targets, thereby providing an additional source of antigens for cross-presentation by DCs (Fig. 2, I ). These assumptions require further in vivo experiments for instance in the MCMV model.
Role of cross-presentation to bypass viral subversion and in moulding T cell repertoire
To further support the hypothesis that immunodominance hierarchy and broadness of T cell repertoire could correlate with the presence of high dose antigens as well as with antigens released by destruction of infected cells, we suggested that DCs could play a major role in both sensing and killing of infected cells in their vicinity. Since infected DCs could be paralysed [4] and made unable to ensure activation of In an in vitro model where HCMV-infected Wbroblasts were co-cultured with monocyte-derived dendritic cells, we demonstrated that immature DCs (iDC) acquired a mature phenotype (mDC), as assessed by an up-regulation of CD80, CD86 and CD83 expression on the cell surface and by the secretion of huge amounts of TNF- [24, 25] . We further demonstrated that HCMV-infected Wbroblasts were sensitive to apoptosis mediated by TNF-, but only within the Wrst hours after addition of the virus. Indeed, at later stages after infection, cells are protected by UL36 and UL37 anti-apoptotic functions acting on the death initiating signaling complex (DISC) and mitochondria, respectively [26, 27] . We then argued in favour of a scenario where stimulated DCs acquired the ability to kill adjacent infected cells through secretion of death ligands such as TNF- (Fig. 2, II) as we recently demonstrated in a co-culture model where iDC were added to infected Wbroblasts in the presence of a pan-caspase inhibitor. We further demonstrated that in these conditions DCs could internalize pp65 associated with early apoptotic and necrotic Wbroblasts for processing and cross-presentation to CD8+ T cells but with less eYciency when Wbroblasts were treated with inhibitors of caspases [19, 25] . Indeed, ingestion of dead cells by DCs is thought to provide one of the strongest activation signals for cross-presentation to CD8+ T cells and we observed that resistance of Wbroblasts to apoptosis in later stages of infection contributed to reduce the eYciency of cross-presentation [25] . Proposed scenarios for cross-presentation have been recently reviewed [28] and are depicted in Fig. 3 . The Wrst scenario is based on the export of antigens from endocytic/phagocytic vesicles to the cytosol allowing their delivery into the direct MHC class I pathway where they are processed into peptides by the same proteasomal degradation pathway that is used for endogenously produced antigens. In the second scenario, phagocytosis of particulate antigens initiates the fusion with endoplasmic reticulum membranes and gives rise to a novel organelle with autonomous processing and presenting capacities. Processed antigens are then exported to the cytosol by a translocation channel Sec61, coated by the ubiquitinating complex and recaptured by the phagosome-associated proteasomal machinery. Peptides with proper epitope structure are then retro-translocated by TAP molecules into the phagosome where they are loaded onto the MHC-I-2 -microglobulin dimers before being recycled back to the cell membrane. Interestingly, when DCs were added to lateinfected Wbroblasts their maturation was inhibited under the eVect of cytokines such as TGF-and of the virokine UL111a (cmvIL-10) secreted by infected Wbroblasts, and their ability to induce activation of anti-pp65 CD8+ T cells was impaired [24, 25] . At a time where Wbroblasts are sensitive to dendritic cell-induced apoptosis, several viral antigens are available for cross-presentation, including tegument and envelope proteins such as pp65, pp150, pp28, gB, gH derived from the input virus, either associated with dead cells or in soluble forms. Neosynthesized IE and E proteins could be as well available at this time point. Accordingly, it could be expected that in primary response, naive CD8+ T cells directed against these IE, E and L viral antigens could be activated, providing an explanation for the presence of a broad repertoire of memory T cells in HCMV-seropositive donors. The immunodominance of some viral antigens may also reXect their relative expression level at a time when they could be internalized by DCs and before the immunosuppressive eVect of TGF-and cmvIL-10. Then, shape and size of the memory T cell repertoire could correlate with the nature and amount of viral antigens cross-presented by DCs, but patterns of eVector T cells frequencies in HCMV-seropositive donors, as recently assessed [23] , could reXect expansion of T cells against recall antigens following re-infection and/or reactivation. History of recall infections and reactivation in a given donor may explain reversal in the immunodominance hierarchy which may be inXuenced by diVerential antigen presentation during primary and secondary responses supposed to involve dendritic and non-dendritic cells, respectively. Analysis of T cell response in transplanted patients who did not develop HCMV disease showed contrasting results. Indeed, high frequencies of IE1-but not pp65-speciWc CD8+ T cells were found protective in one case [29] whereas, rising numbers of pp65-speciWc T cells correlated with immune reconstitution in another case [30] . Interestingly, all patients protected by IE1-specifc T cells were HCMV-seropositive before transplantation suggesting that viral reactivation was responsible for expansion of CTL against IE1 which is produced in large amounts in the IE phase. In contrast, all patients with high counts of pp65-speciWc CTL received a graft from HCMV-seropositive donors suggesting that re-infection could be responsible for expansion of CTL directed against incoming pp65. These results suggest once more that the expansion of virus-specifc CD8+ T cells in secondary responses could depend on the timing of antigen expression and could be regulated by cross-competition favoring T cells that are able to rapidly detect infected cells as demonstrated recently in a mouse model of Poxvirus infection [31] .
In conclusion, interplay between dendritic cells and HCMV in primary infection may favour activation of naive T cells with speciWcity for various viral antigens provided that they have been captured by uninfected DCs but their ability to proliferate and to control virus spreading in secondary responses may depend on conditions under which re-infection and reactivation occur in the host. Relevance of cross-presentation in T cell response against viral infections was recently highlighted by data reporting the ability of plasmacytoid dendritic cells (pDCs) to cross-present HIVderived antigens to CD8+ T cells [32] . A better knowledge of cross-presentation function by myeloid and plasmacytoid DCs in shaping T cell response against HCMV antigens may help to improve vaccine design and cellular immunotherapy.
